N- Ac- Nal(1)- 4- Cl- Phe(2)- Trp(3)- Cit(6)- AlaNH2(10)- LHRH (SB 30)
LHRH antagonist; RN given refers to (D-Ala-D-Phe-D-Trp-L-Ser-L-Tyr-D-Orn-L-Leu-L-Arg-L-Pro-D-Ala)-isomer; RN for cpd without isomeric designation not avail 10/90
Also Known As:
SB 30; LHRH, N-Ac-Nal(1)-4-Cl-Phe(2)-Trp(3)-Cit(6)-AlaNH2(10)-; GnRH, N-Ac-Nal(1)-4-Cl-Phe(2)-Trp(3)-Cit(6)-AlaNH2(10)-; LHRH, N-acetyl-(2-naphthalenyl)alanyl(1)-4-chlorophenylalanyl(2)-tryptophyl(3)-citrullinyl(6)-alaninamide(10)-; N-Ac-1-(2-Nal)-2-(4-Cl-Phe)-3-Trp-6-Cit-10-AlaNH2-LHRH; SB-30
Networked: 2
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Experts
1. | Adelakun, Sunday:
1 article
(11/2018)
|
2. | Aniah, Julius:
1 article
(11/2018)
|
3. | Omotoso, Olusegun:
1 article
(11/2018)
|
4. | Oyewo, Oyebowale:
1 article
(11/2018)
|
5. | Gadsden, Jeff:
1 article
(05/2013)
|
6. | Gandhi, Kishor:
1 article
(05/2013)
|
7. | Gratenstein, Kimberly:
1 article
(05/2013)
|
8. | Hadzic, Admir:
1 article
(05/2013)
|
9. | Kwofie, Kwesi:
1 article
(05/2013)
|
10. | McCally, Colleen Mitgang:
1 article
(05/2013)
|
Related Diseases
Related Drugs and Biologics
Related Therapies and Procedures